Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - bumetanide 1mg;   - tablet - 1 mg - active: bumetanide 1mg   excipient: agar copovidone hydrated silica lactose monohydrate magnesium stearate maize starch polysorbate 80 purified talc - indicated for the treatment of oedema, particularly that associated with congestive heart failure, hepatic and renal diseases including the nephrotic syndrome and acute pulmonary oedema.

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - cefazolin sodium 1.048 g equivalent to cefazolin 1 g - powder for injection - 1 g - active: cefazolin sodium 1.048 g equivalent to cefazolin 1 g - respiratory tract infection due to s. pneumoniae, klebsiella species, h. influenzae, staph. aureus (penicillin-sensitive and penicillin-resistant), and group a beta-haemolytic streptococci. injectable benzathine penicillin is considered to be the drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cefazolin is effective in the eradication of streptococci from the nasopharynx; however, data establishing the efficacy of cephazolin in the subsequent prevention of rheumatic fever are not available at present. appropriate culture and susceptibility studies should be performed to determine susceptibility of the causative organism to cefazolin.

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - ceftriaxone sodium 1.19 g equivalent to ceftriaxone 1 g - powder for injection - 1 g - active: ceftriaxone sodium 1.19 g equivalent to ceftriaxone 1 g - ceftriaxone sodium is indicated for the treatment of lower respiratory tract infections when caused by susceptible aerobic organisms

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - ceftriaxone sodium 2.39 g equivalent to ceftriaxone 2 g - powder for injection - 2 g - active: ceftriaxone sodium 2.39 g equivalent to ceftriaxone 2 g - ceftriaxone sodium is indicated for the treatment of lower respiratory tract infections when caused by susceptible aerobic organisms

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

multichem nz limited - cefazolin sodium 1.048 g equivalent to cephazolin 1 g;   - powder for injection - 1 g - active: cefazolin sodium 1.048 g equivalent to cephazolin 1 g  

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

multichem nz limited - cefazolin sodium 2.096 g equivalent to cefazolin 2 g;   - powder for injection - 2 g - active: cefazolin sodium 2.096 g equivalent to cefazolin 2 g  

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

multichem nz limited - cefazolin sodium 524mg equivalent to cephazolin 500 mg;   - powder for injection - 500 mg - active: cefazolin sodium 524mg equivalent to cephazolin 500 mg  

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - sulfacetamide sodium monohydrate 100 mg/ml - eye drops, solution - 10% w/v - active: sulfacetamide sodium monohydrate 100 mg/ml excipient: methyl hydroxybenzoate methylcellulose monobasic sodium phosphate propyl hydroxybenzoate purified water sodium thiosulfate - for the treatment of acute and chronic bacterial conjunctivitis, corneal ulcer, and other superficial ocular infections from susceptible micro-organisms, and as an adjunct to systemic sulfonamide therapy of trachoma.

Nigeria - inglés - NAFDAC (National Agency for Food and Drugs Administration and Control)

trimethoprim - 40mg sulphanethoxazole 200mg/5ml.

Malta - inglés - Malta Medicines Authority

laboratori guidotti s.p.a. via livornese, 897, 56010 pisa – la vettola, italy - glibenclamide, metformin hydrochloride - film-coated tablet - glibenclamide 2.5 mg metformin hydrochloride 400 mg - drugs used in diabetes